| Identification | Back Directory | [Name]
PF-04971729 | [CAS]
1210344-57-2 | [Synonyms]
CS-186
MK-8835
PF-04971729
Ertugliflozin
PF 04971729-00
Ertugliflozin Base
Ertugliflozin, >=98%
Ertugliflozin MK-8835
PF-04971729 USP/EP/BP
PF-04971729/PF04971729
Leuco methylthioninium
PF-04971729/Ertugliflozin
Ertugliflozin/PF-04971729
Ertugliflozin : PF 04971729-00
ERTUGLIFLOZIN;PF04971729;PF 04971729
PF04971729;PF 04971729 (ERTUGLIFLOZIN)
1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-β-L-idopyranose
β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-
1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose
(1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
(1S,2S,3S,4R,5S)-(2,3,4-TRIS-BENZYLOXY-5-(4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL)-68-DIOXA-BICYCLO(3.2.1)OCT-1-YL)-METHANOL
(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose PF-04971729(Ertugliflozin) | [Molecular Formula]
C22H25ClO7 | [MDL Number]
MFCD21609259 | [MOL File]
1210344-57-2.mol | [Molecular Weight]
436.88 |
| Chemical Properties | Back Directory | [Melting point ]
65 - 66oC | [Boiling point ]
630.5±55.0 °C(Predicted) | [density ]
1.455 | [storage temp. ]
Sealed in dry,Store in freezer, under -20°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
12.95±0.70(Predicted) | [color ]
White to Off-White |
| Hazard Information | Back Directory | [Uses]
Ertugliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes. | [Definition]
ChEBI: Ertugliflozin is a diarylmethane. | [storage]
Store at -20°C |
|
|